These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 946524)

  • 21. [Studies on the persistence of immunity 14-15 years after vaccination with a live measles vaccine].
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):389-91. PubMed ID: 2598095
    [No Abstract]   [Full Text] [Related]  

  • 22. Immune status following measles vaccination in infants and evaluation for the need of revaccination.
    Dutta AK; Singhal PK; Khare S; Kumari S; Mathur R; Mullick DN
    Indian Pediatr; 1989 Aug; 26(8):765-72. PubMed ID: 2620977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunologic response and reactions to vaccination in children vaccinated against measles. III. Persistence of measles antibodies in children vaccinated in 1972].
    Kańtoch M; Naruszewicz-Lesiuk D; Polna I; Lityńska J
    Przegl Epidemiol; 1976; 30(2):235-41. PubMed ID: 945592
    [No Abstract]   [Full Text] [Related]  

  • 24. Need for measles revaccination in adolescents: correlation with birth date prior to 1972.
    Yeager AS; Harvey B; Crosson FJ; Davis JH; Ross LA; Halonen PE
    J Pediatr; 1983 Feb; 102(2):191-5. PubMed ID: 6822921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measles IgA in the nasal washings of adult volunteers and children immunized intranasally with measles vaccine L-16.
    Liashenko VA; Krasnova VP; Youminova NV
    Hum Antibodies; 1999; 9(3):143-8. PubMed ID: 10690626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serological survey for rubella and measles antibodies among first graders.
    Schiff GM; Linnemann CC; Shea L; Witte JJ; Ackerman JH; Stapleton L; Elsea WR; Agna M
    JAMA; 1974 Jan; 227(1):49-52. PubMed ID: 4859626
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinico-laboratory indices of children revaccinated against measles].
    Sorokina EA; Bystriakova LV; Sertakova ZL; Terekhova LE
    Tr Inst Im Pastera; 1985; 62():50-4. PubMed ID: 2954276
    [No Abstract]   [Full Text] [Related]  

  • 28. [Serological evaluation of immunization against measles with 2 doses administered at 6 and 11 months of age: a prospective study].
    Pannuti CS; de Souza VA; Sato HK; Fink MC; Ribeiro MI; Hisi SK; Castelo A; de Mendonça JS
    Rev Inst Med Trop Sao Paulo; 1990; 32(6):450-5. PubMed ID: 2135492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seroepidemiology of measles in Delhi: implications for age of vaccination.
    Khare S; Dutta A; Kumari S; Basu RN
    Indian J Pediatr; 1987; 54(5):711-5. PubMed ID: 3501410
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunological effectiveness of a booster inoculation against measles in children remaining seronegative after vaccination].
    Bolomovskiĭ VM; Gelikman BG; Titova NS; Slavnitskaia IV; Auzinia AV
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jul; (7):100-6. PubMed ID: 6333122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The validation of the expediency of a review of the times for revaccinating children against measles].
    Rusakova EV; Bezuglova MS; Vasil'eva VI; Frank KD; Drynov ID; Filatov NN; Demskiĭ VI
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Aug; (8):51-4. PubMed ID: 1950287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Measles epidemiology and the status of specific immunity in Novgorod Province during a mass immunization].
    Golubeva LI; Brantseva IV
    Tr Inst Im Pastera; 1985; 62():68-72. PubMed ID: 2954277
    [No Abstract]   [Full Text] [Related]  

  • 33. Measles seroepidemiology among adolescents and young adults: response to revaccination.
    Saffar MJ; Alraza-Amiri M; Ajami A; Baba-Mahmoodi F; Khalilian AR; Vahidshahi C; Shamsizadeh A
    East Mediterr Health J; 2006 Sep; 12(5):573-81. PubMed ID: 17333796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effectiveness of measles inoculations in the Hungarian People's Republic].
    Erdös L
    Tr Inst Im Pastera; 1979; 53():19-25. PubMed ID: 262709
    [No Abstract]   [Full Text] [Related]  

  • 35. [Program for carrying out a campaign of controlled measles vaccination in a local area].
    Santoro R; Polo M; Rigoli E; Scardellato U; Annesi I; Grandolfo ME; Novello F
    Ann Ist Super Sanita; 1982; 18(3):441-4. PubMed ID: 7187830
    [No Abstract]   [Full Text] [Related]  

  • 36. Measles vaccination in infants.
    Jones PH
    JAMA; 1982 Mar; 247(9):1273-4. PubMed ID: 7062536
    [No Abstract]   [Full Text] [Related]  

  • 37. [Serological study of postvaccinal measles immunity in the absence of a booster effect and in measles foci].
    Chudnaia LM; Fastovskaia BN; Shekhter AB; Orekhova GI; Dzhulaĭ AS
    Tr Inst Im Pastera; 1979; 53():71-5. PubMed ID: 262711
    [No Abstract]   [Full Text] [Related]  

  • 38. Measles vaccine failures: lack of sustained measles-specific immunoglobulin G responses in revaccinated adolescents and young adults.
    Cohn ML; Robinson ED; Faerber M; Thomas D; Geyer S; Peters S; Martin M; Martin A; Sobel D; Jones R
    Pediatr Infect Dis J; 1994 Jan; 13(1):34-8. PubMed ID: 8170730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The role of consultative offices on immunoprophylaxis in organizing epidemiologic surveillance of measles].
    Ignatov SA; Radomskaia FS; Makarova EN; Leĭko AP; Itkina EN; Komarevskaia RV
    Vrach Delo; 1990 Jan; (1):121-3. PubMed ID: 2330697
    [No Abstract]   [Full Text] [Related]  

  • 40. II. Primary and secondary immunological response of experimental animals to attenuated and nonattenuated measles virus.
    Aleksandrowicz J; Polna I; Sadowski W
    Acta Microbiol Pol A; 1973; 5(3):139-45. PubMed ID: 4203633
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.